Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Hydrocodone bitartrate 7.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
brompheniraminmaleat 2 mg + guaifenesin 200 mg + hydrocodonhydrogentartrat 5 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
brompheniraminmaleat 2 mg + hydrocodonhydrogentartrat 1,7 mg + pseudoephedrinhydrochlorid 30 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
chlorpheniraminmaleat 2 mg + hydrocodonbitartrat 2,5 mg + phenylephrinhydrochlorid 5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
homatropinmethylbromid 1,5 mg + hydrocodonbitartrat 5 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Hydrocodone bitartrate 7.5 mg and ibuprofen 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
hydrocodonhydrogentartrat 5 mg + kaliumguaiacolsulfonat 300 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
acetylsalicylsyre + hydrocodonbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
brompheniraminmaleat + hydrocodonhydrogentartrat + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
hydrocodonbitartrat + ibuprofen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
homatropinmethylbromid + hydrocodonbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
chlorpheniraminmaleat + hydrocodonbitartrat + phenylephrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
hydrocodonhydrogentartrat + kaliumguaiacolsulfonat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
hydrocodonbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Hydrocodone bitartrate 5 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Hydrocodone bitartrate 10 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Hydrocodone bitartrate 5 mg and paracetamol 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Acetaminophen + hydrocodone bitartrate 500mg/7.5mg elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Hydrocodone bitartrate 7.5 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Hydrocodone bitartrate 5 mg and paracetamol 556 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Hydrocodone bitartrate 10 mg and paracetamol 660 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
paracetamol + hydrocodonbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Product containing precisely hydrocodone bitartrate 2.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
paracetamol 325 mg + hydrocodon 7,5 mg 15 ml oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
paracetamol 500 mg + hydrocodon 7,5 mg 15 ml oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
paracetamol 500 mg + hydrocodon 5 mg 15 ml oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Hydrocodone bitartrate 2.5 mg and ibuprofen 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Hydrocodone bitartrate 5 mg and ibuprofen 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Hydrocodone bitartrate 10 mg and ibuprofen 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Acetaminophen 325mg/hydrocodone 10mg 15mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Hydrocodone bitartrate 2.5 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
|
Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 5 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 5 mg and paracetamol 325 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 10 mg and paracetamol 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 5 mg and paracetamol 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 5 mg and paracetamol 500 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 7.5 mg and paracetamol 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 5 mg and paracetamol 556 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 5 mg and paracetamol 556 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 10 mg and paracetamol 660 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 750 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 2.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 7.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 7.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 7.5 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 7.5 mg and paracetamol 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 7.5 mg and ibuprofen 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 5 mg and ibuprofen 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 5 mg and ibuprofen 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 2.5 mg and ibuprofen 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 2.5 mg and ibuprofen 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 2.5 mg and paracetamol 325 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 10 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 10 mg and paracetamol 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 10 mg and paracetamol 660 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 10 mg and paracetamol 660 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 7.5 mg and ibuprofen 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 7.5 mg and ibuprofen 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 10 mg and ibuprofen 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 10 mg and ibuprofen 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 2.5 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 2.5 mg and paracetamol 325 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocodone bitartrate |
Inferred relationship |
Some |
1 |